NewEdge Advisors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03K | Hold |
300
| – | – | ﹤0.01% | 3713 |
|
|
2025
Q1 | $669 | Hold |
300
| – | – | ﹤0.01% | 3674 |
|
|
2024
Q4 | $879 | Hold |
300
| – | – | ﹤0.01% | 3584 |
|
|
2024
Q3 | $780 | Sell |
300
-300
| -50% | -$780 | ﹤0.01% | 3557 |
|
|
2024
Q2 | $1.78K | Hold |
600
| – | – | ﹤0.01% | 3361 |
|
|
2024
Q1 | $2.72K | Buy |
600
+300
| +100% | +$1.36K | ﹤0.01% | 3310 |
|
|
2023
Q4 | $1.71K | Hold |
300
| – | – | ﹤0.01% | 3370 |
|
|
2023
Q3 | $1.38K | Hold |
300
| – | – | ﹤0.01% | 3121 |
|
|
2023
Q2 | $1.94K | Hold |
300
| – | – | ﹤0.01% | 3106 |
|
|
2023
Q1 | $2.26K | Sell |
300
-420
| -58% | -$3.17K | ﹤0.01% | 3002 |
|
|
2022
Q4 | $5.07K | Buy |
+720
| New | +$5.07K | ﹤0.01% | 2585 |
|